Milestone Scientific (MLSS) Common Equity (2010 - 2026)

Milestone Scientific has disclosed Common Equity across 17 years of filings, most recently posting $2.3 million for Q1 2026.

• Common Equity for Q1 2026 came in at $2.3 million, down 48.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 48.8% YoY), and the FY2025 annual result was $2.8 million, down 51.78% from the prior year.
• Common Equity came in at $2.3 million for Q1 2026 at Milestone Scientific, down from $2.8 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $14.8 million in Q1 2022 to a low of $2.3 million in Q1 2026.
• The 5-year median for Common Equity is $7.5 million (2024), against an average of $7.3 million.
• Across the five-year window, Common Equity gained 3.27% in 2024 and plunged 64.7% in 2025, its largest moves.
• Milestone Scientific's Common Equity stood at $10.0 million in 2022, then dropped by 19.93% to $8.0 million in 2023, then declined by 27.21% to $5.8 million in 2024, then sank by 51.78% to $2.8 million in 2025, then decreased by 18.76% to $2.3 million in 2026.
• The last three Common Equity figures came in at $2.3 million (Q1 2026), $2.8 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.